BB vs IMRX · P/E 117, rev $549.1M vs $124.2M cap
BlackBerry Ltd (BB) versus Immuneering Corp (IMRX) — a side-by-side from cached financials, not a winner call.
BlackBerry Ltd (BB) is a software - infrastructure company listed on US.
Immuneering Corp (IMRX) is a biotechnology company listed on US.
Latest reported BB revenue for 2026-02-28 was $549.1M. Net income was $53.2M. Revenue was up 2.7% from 2025-02-28 to 2026-02-28. BB currently screens at market cap $6.14B and trailing P/E 116.5.
Latest reported IMRX revenue for 2023-12-31 was $0. Net income was -$53.5M. Revenue was down 100.0% from 2022-12-31 to 2023-12-31. IMRX currently screens at market cap $124.2M.
BB currently screens at market cap $6.14B and trailing P/E 116.5. IMRX currently screens at market cap $124.2M.
Not investment advice. Open the BB and IMRX stock pages for the full models.
Not investment advice.